BRTX: BioRestorative Therapies Inc

BRTX新闻

• 01:38 BioRestorative Therapies完成500万美元公开募股
• 01:37 BioRestorative Therapies closes $5 million public offering
• 02:32 BioRestorative Therapies Q3 每股收益 超出预期, 营收 低于预期
• 02:32 BioRestorative Therapies earnings beat by $0.05, revenue fell short of estimates
• 23:25 Biorestorative Therapies, Inc. (BRTX) Reports Q3 Loss, Lags Revenue Estimates
• 19:01 Cisco, Flutter, Manulife and more set to report earnings Wednesday
• 14:10 CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates
• 13:40 Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?
• 18:47 BioRestorative Therapies股价在110万美元注册发行后下跌
• 18:46 BioRestorative Therapies stock falls after $1.1M registered offering
• 18:34 BioRestorative Therapies通过注册发行筹集108.5万美元
• 18:33 BioRestorative Therapies raises $1.085 million in registered offering
• 13:40 Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
• 13:40 Are Medical Stocks Lagging Black Diamond Therapeutics (BDTX) This Year?
• 02:24 BioRestorative Therapies earnings beat by $0.08, revenue fell short of estimates
• 23:53 BioRestorative Therapies, Inc. (BRTX) Q2 2025 Earnings Call Transcript
• 22:05 Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates
• 22:35 Zymeworks Inc. (ZYME) Tops Q2 Earnings and Revenue Estimates
• 12:15 Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates
• 17:34 From Phase 2 Trial Results To Expansion Mode: A Look At BioRestorative's Novel Approach To Treating Chronic Pain - BioRestorative Therapies (NASDAQ:BRTX)
• 13:52 BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
• 11:53 BioRestorative reports positive data from BRTX-100 stem cell therapy trial
• 11:56 BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025
• 10:26 BioRestorative Therapies earnings missed by $0.38, revenue fell short of estimates